Nextage Therapeutics Ltd (TLV:NXTG)
Israel
· Delayed Price · Currency is ILS · Price in ILA 77.90
+0.40 (0.52%)
At close: Sep 30, 2025
Nextage Therapeutics Revenue
In the year 2024, Nextage Therapeutics had annual revenue of 413.00K ILS, down -52.85%. Nextage Therapeutics had revenue of 104.00K in the half year ending December 31, 2024.
Revenue
413.00K
Revenue Growth
-52.85%
P/S Ratio
63.56
Revenue / Employee
13.32K
Employees
31
Market Cap
26.25M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 413.00K | -463.00K | -52.85% |
| Dec 31, 2023 | 876.00K | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | 91.00K | -100.00K | -52.36% |
| Dec 31, 2020 | 191.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 55.02B |
| Danel (Adir Yeoshua) | 2.87B |
| Kamada | 578.74M |
| BrainsWay | 162.56M |
| BioLight Life Sciences | 21.00K |
| Identi Healthcare | 10.93M |
| Bio-View | 17.88M |
| Evogene | 26.54M |